References
- Pollok KE, Kim YJ, Zhou Z, Hurtado J, Kim KK, Pickard RT, Inducible T cell antigen 4-1BB analysis of expression and function. J Immunol 1993;150:771–81.
- Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity. Nat Rev Immunol 2003;3:609–20.
- Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;25:23–68.
- Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705–14.
- El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817–23.
- Tilg H. New insights into the mechanisms of interferon α: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 1997;112:1017–21.
- Ji X, Cheung R, Cooper S, Li Q, Greenberg HB, He XS. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 2003;37:610–21.
- Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005;42:702–10.
- Cheng PN, Wei YL, Chang TT, Chen JS, Young KC. Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells. J Med Virol 2008;80:989–96.
- Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999;162:5584–91.
- Maerten P, Geboes K, De Hertogh G, Shen C, Cadot P, Bullens DM, Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease. Clin Immunol 2004;112:239–46.
- Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000;118:346–55.
- Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002;123:1070–83.
- Kamal SM, Ismail A, Graham CS, He Q, Rasenack JW, Peters T, Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology 2004;39:1721–31.
- Tatsumi T, Takehara T, Miyagi T, Nakazuru S, Mita E, Kanto T, Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-α and ribavirin combination therapy in patients with chronic hepatitis C virus infection. Hepatol Res 2011;41:30–8.
- Arends JE, Claassen MA, van den Berg CH, Nanlohy NM, van Erpecum KJ, Baak BC, T-cell responses at baseline and during therapy with peginterferon-alpha and ribavirin are not associated with outcome in chronic hepatitis C infected patients. Antiviral Res 2010;87:353–60.